Intuitive Surgical Inc IUI1
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IUI1 is a good fit for your portfolio.
News
-
Intuitive Surgical 1Q Profit Rises on More Procedures, Installed Systems
-
Intuitive Surgical Gets FDA OK for Latest Robotic System
-
AI stocks in the S&P 500 have outperformed this year - and not just the 'Magnificent Seven'
-
Intuitive Surgical 4Q Revenue Rises on Procedure Growth
-
Intuitive Surgical on Pace for Record High Close — Data Talk
-
Intuitive Surgical leads S&P 500 gainers as analysts welcome bullish guidance for 2024
-
Intuitive Surgical Up Over 5%, on Pace for Largest Percent Increase Since April 2023 — Data Talk
-
Intuitive Surgical stock rallies on sales forecast, as demand for robot surgeons rises
Trading Information
- Previous Close Price
- $349.80
- Day Range
- $348.20–355.05
- 52-Week Range
- $180.00–305.40
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $125.41 Bil
- Volume/Avg
- 0 / 208
Key Statistics
- Price/Earnings (Normalized)
- 64.16
- Price/Sales
- 18.80
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.05%
Company Profile
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Large Growth
- Total Number of Employees
- 13,676
- Website
- https://www.intuitive.com
Competitors
Valuation
Metric
|
IUI1
|
MDT
|
SYK
|
---|---|---|---|
Price/Earnings (Normalized) | 64.16 | 15.10 | 29.97 |
Price/Book Value | 9.70 | 2.10 | 6.53 |
Price/Sales | 18.80 | 3.37 | 6.02 |
Price/Cash Flow | 49.45 | 14.87 | 28.20 |
Price/Earnings
IUI1
MDT
SYK
Financial Strength
Metric
|
IUI1
|
MDT
|
SYK
|
---|---|---|---|
Quick Ratio | 3.91 | 1.46 | 0.85 |
Current Ratio | 4.76 | 2.30 | 1.71 |
Interest Coverage | — | 8.86 | 12.00 |
Quick Ratio
IUI1
MDT
SYK
Profitability
Metric
|
IUI1
|
MDT
|
SYK
|
---|---|---|---|
Return on Assets (Normalized) | 14.56% | 7.75% | 10.98% |
Return on Equity (Normalized) | 17.02% | 13.75% | 23.40% |
Return on Invested Capital (Normalized) | 15.43% | 9.87% | 14.61% |
Return on Assets
IUI1
MDT
SYK
Medical Instruments & Supplies Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Lxmqcvfvyw | Hvfb | $135.3 Bil | |
BDX
| Becton Dickinson & Co | Sblnzpbj | Cbnntt | $67.8 Bil | |
ALC
| Alcon Inc | Tdjwmvlp | Ldcnrwm | $39.1 Bil | |
RMD
| ResMed Inc | Kmvnwxybvr | Ggsszx | $31.9 Bil | |
CLPBY
| Coloplast A/S ADR | Btbkywtvz | Vzpw | $27.8 Bil | |
WST
| West Pharmaceutical Services Inc | Qvypvvkpp | Fthgf | $26.7 Bil | |
BAX
| Baxter International Inc | Zwzwxhks | Lxwrl | $18.8 Bil | |
COO
| The Cooper Companies Inc | Shfgrqh | Jlwslq | $18.0 Bil | |
HOLX
| Hologic Inc | Gfvspsmq | Cljmr | $17.9 Bil | |
ATR
| AptarGroup Inc | Dprplkkt | Jmxqfp | $9.7 Bil |